Influence of methylprednisolone on cytokine balance during cardiac surgery

Critical Care Medicine

Volumn 27, Issue 3, 1999, Pages 545-548

  Kawamura, Takae ^a   Inada, Katsuya ^a   Nara, Noriko ^a   Wakusawa, Reiji ^a   Endo, Shigeatsu ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti inflammatory cytokines; Cardiac surgery; Cardiopulmonary bypass; Cytokine balance; Interleukin 10; Interleukin 1 receptor antagonist; Interleukin 6; Interleukin 8; Methylprednisolone

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CELL PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; INFLAMMATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION;

EID: 0032907965     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199903000-00033     Document Type: Article

References (35)

1. 1. Casey LC: Roles of cytokines in the pathogenosis of cardiopulmonary induced multisystem organ failure. Ann Thorac Surg 1993; 56:S92-S96
2. 2. Llamas R, Forthman HJ: Respiratory distress syndrome in the adult after cardiopulmonary bypass. JAMA 1973; 225:1183-1186
3. 3. Butler J, Chong GTL, Baigrie RJ, et al: Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992; 53:833-838
4. 4. Mc Bride WT, Armstrong MA, Cockard AD, et al: Selective reduction in leucocyte surface marker expression following high dose fentanyl admimistration at cardiac surgery. Br J Anaesth 1994; 73:717-718
5. 5. Kawamura T, Wakusawa R, Okada K, et al: Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 1993; 40:1016-1021
6. 6. Kalfin RE, Engelman RM, Rousou JA, et al: Induction of IL-8 expression during cardiopulmonary bypass. Circulation 1993; 88:2401-2406
7. 7. Lahat N, Zlotnick AY, Shtiller R, et al: Serum levels of IL-1, IL-6 and TNF in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 1992; 89:255-260
8. 8. Miller LC, Lynch EA, Isa S, et al: Balance of synovial fluid IL-1 and IL-1 receptor antagonist and reconery from Lyme arthritis. Lancet 1993; 341: 146-148
9. 9. Girardin E, Roux-Lmbard P, Grau GE, et al: Imbalance between tumour necrosis factor alpha and soluble TNF receptor levels in severe meningococcemia. Immunology 1992; 76:20-23
10. 10. Niazi Z, Flodin P, Joyce L, et al: Effects of glucocorticoids in patients undergoing coronary artery bypass surgery. Chest 1979; 76:262-268
11. 11. Andersen LW, Baek L, Thomsen BS, et al: The effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery. J Cardiothorac Anesth 1989; 3:544-549
12. 12. Cavarocchi NC, Pluth JR, Schaff HV, et al: Complement activation during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986; 91:252-258
13. 13. Hill GE, Snider S, Gallbraith T, et al: Glucocorticoid reduction of bronchial epithelial inflammation during cardiopulmonary bypass. Am J Respir Crit Care Med 1995; 152:1791-1795
14. 14. Ruggeroli AC, Carruthers RG, Pohorecki R, et al: Cardiopulmonary bypass-induced inflammation: Steroids vs. aprotinin. Anesthesiology 1995; 83:A83
15. 15 Jansen NJG, van Oeveren W, Borek LVD, et al: Inhibition of dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 102:515-525
16. 16. Kawamura T, Inada K, Okada H, et al: Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery. Can J Anaesth 1995; 42: 399-403
17. 17. Casey LC: Roles of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993; 56:S92-S96
18. 18. Kirklin JK, Westaly S, Blackstone EH, et al: Complement and the lamaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86:845-857
19. 19. Jansen NJG, Van Oeveren W, Gu YJ, et al: Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54:744-747
20. 20. Mitchell SF, Rosemary AH, Li S, et al: Interleukin-6 (IL-6) as a mediator of stunned myocardium. Am J Cardiol 1993; 71:1231-1232
21. 21. Messent M, Sullivan K, Keogh BF, et al: Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anaesthesia 1992; 47:267-268
22. 22. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24:1125-1128
23. 23. Kawamura T, Wakusawa R, Inada K: Interleukin-10 and interleukin-1 receptor antagonists increase during cardiac surgery. Can J Anaesth 1997; 44:38-42
24. 24. Cassatella MA, Meda L, Gasperini S, et al: Interleukin 10 (IL-10) up-regulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukcocytes by delaying mRNA degradation. J Exp Med 1994; 179:1695-1699
25. 25. Wakabayashi G, Ueda M, Shimazu M, et al: Pro and anti-inflammatory cytokines production from human monocyte - The effect of methylprednisolon. Dig Organ Immunol (JPN) 1993; 28:13-17
26. 26. Santos AA, Scheltinga MR, Lynch E, et al: Elaboration of interleukin 1 - Receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch Surg 1993; 128:138-144
27. 27. Tabardel Y, Duchateau J, Schmartz D, et al: Corticosteroid increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996; 119:76-80
28. 28. Hill GE, Alonso A, Thiele GM, et al: Glucocorticoids blunt neutrophil CD11b surface glycoprotion upregulation during cardiopulmonary bypass in humans. Anesth Analg 1994; 79:23-27
29. 29. Jansen NJG, van Oeveren W, van Vliet M, et al: The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac Surg 1991; 5: 211-217
30. 30. Huang ZB, Eden E: Effect of corticosteroids on IL-1β and TNF-α release by alveolar macrophages from patients with AIDS and pneumocystis carini pneumonia. Chest 1993; 104:751-755
31. 31. Redl H, Lamche H, Paul E, et al: Effect of methylprednisolon, prednisolone, and lexamethasone on granulocyte function and complement activation. Prog Clin Biol Res 1987; 236B:261-272
32. 32. Zitnik RJ, Whiting NL, Elias JA: Glucocorticoid inhibition of interleukin-1 induced interleukin-6 production by human lung fibroblasts: Evidence for transcriptional and post-transcriptional regulatory mechanism. Am J Respir Cell Mol Biol 1994; 10: 643-650
33. 33. Kimmel SC, van de Stouwe MJ, Levin RI, et al: A final common pathway for anti-inflammatory agents: Inhibition of leukocyte-endothelial interactions. Trans Assoc Am Physicians 1991; 104:113-124
34. 34. Finkel MS, Oddis CV, Jacob TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-389
35. 35. Radomski MW, Palmer RM, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87:10043-10047